Step by Stepa HemeOncBuddy patient portal

Rucaparib

Illustration: Rucaparib

Say it: roo-KAP-a-rib · Brand names: Rubraca

Rucaparib is a targeted therapy pill called a PARP inhibitor that stops cancer cells from repairing their damaged DNA.

What it is

Cells use proteins called PARP to fix damaged DNA. Cancer cells with a BRCA gene change already have trouble fixing DNA. When rucaparib blocks PARP, these cancer cells cannot repair themselves and die.

Often used for

How you get it

Rucaparib is a pill you take by mouth at home, twice a day, about 12 hours apart, with or without food. Your schedule may be different.

Common side effects and what helps

Call your care team right away if you have

Before you start, tell your team

Good to know

At home

Questions to ask

Side effect guides

Sources

Quick answers

What is Rucaparib?
Rucaparib is a targeted therapy pill called a PARP inhibitor that stops cancer cells from repairing their damaged DNA. Brand names: Rubraca.
What is Rucaparib used for?
ovarian, fallopian tube, or primary peritoneal cancer with a BRCA gene change, after chemotherapy has worked; prostate cancer with a BRCA gene change that has spread.
How is Rucaparib given?
Rucaparib is a pill you take by mouth at home, twice a day, about 12 hours apart, with or without food. Your schedule may be different.
What are the common side effects of Rucaparib?
Feeling sick to your stomach or throwing up. Feeling tired or weak. Low red blood cells (anemia), which can make you tired or short of breath. Changes in liver blood tests. Constipation. Changes in how food tastes. Not feeling hungry or losing weight. Sunburning more easily.
When should I call my care team while taking Rucaparib?
A fever of 100.4 degrees Fahrenheit (38 degrees Celsius) or higher, or chills; Unusual bruising or bleeding, feeling very weak or tired, or getting infections often; Blood in your urine or stool; Feeling dizzy or faint, or not able to keep fluids down.

Last updated: 2026-10-27. Medically reviewed by Veli Bakalov, MD, medical oncologist (October 2026). General education from Step by Step, the patient portal of HemeOncBuddy.